Nitro-G IV injection

Dexa Medica

Ingredients in every ml

Glyceryl Trinitrate 1 mg

Each package contains

10 ampoules of 10 ml

Other details

Dosage form:Injection
Flavour None

W.H.O. classification

ATC Level 1 C - Cardiovascular system
ATC Level 2 C01 - Cardiac Therapy Drugs
ATC Level 3 C01E - Other Cardiac Preparations in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CONSULT YOUR DOCTORSafety of this item for use while operating heavy machinery has not been established. Please consult your doctor.

Available in

Myanmar

Dosage information

18 YEARS OLD AND ABOVE
The dose of nitroglycerin should be adjusted to meet the individual needs of the patient and the responses of the monitored hemodynamic parameters. The recommended dosage range is 10-200 μg/minute but up to 400 μg/minute may be necessary during some surgical procedures.

Surgery
A starting dose of 25 μg/minute is recommended for the control of hypertension, or to produce hypotension during surgery. This may be increased by increments of 25 μg/minute at 5-minute intervals until the blood pressure is stabilized. Doses between 10-200 μg are usually sufficient during surgery, although doses of up to 400 μg/minute have been required in some cases.
The treatment of perioperative myocardial ischemia may be started with a dose of 15-20 μg/minute with subsequent increments of 10-15 μg/minute until the required effect is obtained.

Unresponsive congestive heart failure
The recommended starting dose is 20-25 μg/minute. This may be decreased to 10 μg/minute or increased in steps of 20-25 μg/minute every 15-30 minutes until the desired effect is obtained.

Unstable angina
An initial dose of 10 μg/minute is recommended, with increments of 10 μg/minute being made at approximately 30 minute intervals according to the needs of the patient.

0 TO 18 YEARS OLD
The safety and efficacy has not been established

Indication

– Surgery:
– The rapid control of hypertension during cardiac surgery.
– Reducing blood pressure and maintain controlled hypotension during surgical procedures.
– Controlling myocardial ischemia during and after surgery.
– Unresponsive congestive heart failure secondary to acute myocardial infarction.
– Unstable angina which is refractory to treatment with beta blockers and sublingual nitrates.